Literature DB >> 10360180

Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.

T Schindler1, F Sicheri, A Pico, A Gazit, A Levitzki, J Kuriyan.   

Abstract

The crystal structure of the autoinhibited form of Hck has been determined at 2.0 A resolution, in complex with a specific pyrazolo pyrimidine-type inhibitor, PP1. The activation segment, a key regulatory component of the catalytic domain, is unphosphorylated and is visualized in its entirety. Tyr-416, the site of activating autophosphorylation in the Src family kinases, is positioned such that access to the catalytic machinery is blocked. PP1 is bound at the ATP-binding site of the kinase, and a methylphenyl group on PP1 is inserted into an adjacent hydrophobic pocket. The enlargement of this pocket in autoinhibited Src kinases suggests a route toward the development of inhibitors that are specific for the inactive forms of these proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360180     DOI: 10.1016/s1097-2765(00)80357-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  121 in total

Review 1.  Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Authors:  B J Druker; N B Lydon
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Competing protein:protein interactions are proposed to control the biological switch of the E coli biotin repressor.

Authors:  L H Weaver; K Kwon; D Beckett; B W Matthews
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 3.  Targeting protein kinases with selective and semipromiscuous covalent inhibitors.

Authors:  Rand M Miller; Jack Taunton
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

4.  Modified AutoDock for accurate docking of protein kinase inhibitors.

Authors:  Oleksandr V Buzko; Anthony C Bishop; Kevan M Shokat
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

5.  Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.

Authors:  Keith Q Tanis; Darren Veach; Henry S Duewel; William G Bornmann; Anthony J Koleske
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

6.  MMDB: Entrez's 3D-structure database.

Authors:  Jie Chen; John B Anderson; Carol DeWeese-Scott; Natalie D Fedorova; Lewis Y Geer; Siqian He; David I Hurwitz; John D Jackson; Aviva R Jacobs; Christopher J Lanczycki; Cynthia A Liebert; Chunlei Liu; Thomas Madej; Aron Marchler-Bauer; Gabriele H Marchler; Raja Mazumder; Anastasia N Nikolskaya; Bachoti S Rao; Anna R Panchenko; Benjamin A Shoemaker; Vahan Simonyan; James S Song; Paul A Thiessen; Sona Vasudevan; Yanli Wang; Roxanne A Yamashita; Jodie J Yin; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 7.  Determinants of substrate recognition in nonreceptor tyrosine kinases.

Authors:  W Todd Miller
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

8.  Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.

Authors:  Teodora Pene-Dumitrescu; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

9.  Effect of the SH3-SH2 domain linker sequence on the structure of Hck kinase.

Authors:  Heike Meiselbach; Heinrich Sticht
Journal:  J Mol Model       Date:  2010-11-26       Impact factor: 1.810

10.  Multidomain assembled states of Hck tyrosine kinase in solution.

Authors:  Sichun Yang; Lydia Blachowicz; Lee Makowski; Benoît Roux
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.